Last quarter (Q3 2023), TherapeuticsMD's total revenue was $-53.00K, a decrease of -100.25% from the same quarter last year. In Q3, TherapeuticsMD's net income was $-3.38M. See TherapeuticsMD’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 1.95M	$ 69.96M	$ 2.57M	$ 64.87M	$ 49.65M	$ 16.10M
Cost of Revenue	$ 11.99M	$ 1.40M	$ 1.40M	$ 15.97M	$ 6.33M	$ 2.74M
Gross Profit	$ 13.94M	$ 68.57M	$ 1.17M	$ 48.90M	$ 43.31M	$ 13.36M
Operating Expense	$ 61.58M	$ 67.38M	$ 80.75M	$ 204.44M	$ 194.52M	$ 143.58M
Operating Income	$ 69.57M	$ 1.19M	$ -79.58M	$ -155.54M	$ -151.21M	$ -130.22M
Net Non Operating Interest Income Expense	$ 70.42M	$ -36.06M	$ 32.92M	$ -28.58M	$ -17.38M	$ -4.68M
Other Income Expense	$ 134.12M	$ 117.00K	$ -272.00K	$ 598.00K	$ -7.56M	$ 2.28M
Pretax Income	$ -39.67M	$ 1.07M	$ -79.31M	$ -183.52M	$ -176.14M	$ -132.62M
Tax Provision	$ -290.00K	-	-	$ 0.00	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -41.32M	$ 1.07M	$ -79.31M	$ -183.52M	$ -176.14M	$ -132.62M
Basic EPS	$ -10.62	$ 12.41	-	$ -33.50	$ -0.72	$ -0.59
Diluted EPS	$ -4.49	$ 11.95	$ -21.50	$ -33.50	$ -0.72	$ -0.59
Basic Average Shares	$ 39.70M	$ 9.03M	$ 7.96M	$ 5.51M	$ 246.35M	$ 225.03M
Diluted Average Shares	$ 40.04M	$ 9.37M	$ 7.96M	$ 5.51M	$ 246.35M	$ 225.03M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 73.57M	$ 68.77M	$ 82.15M	$ 220.41M	$ 200.85M	$ 146.32M
Net Income From Continuing And Discontinued Operation	$ -42.62M	$ 112.00M	$ -79.31M	$ -183.52M	$ -176.14M	$ -132.62M
Normalized Income	$ -3.04M	$ 10.32M	-	$ -183.52M	$ -166.09M	$ -132.62M
Interest Expense	-	-	-	$ 26.05M	$ 17.38M	$ 4.68M
EBIT	$ -110.09M	$ 37.14M	$ -112.22M	$ -157.47M	$ -158.76M	$ -127.94M
EBITDA	$ -109.56M	$ 38.33M	$ -111.49M	$ -153.41M	$ -157.37M	$ -127.65M

Currency in USD

TherapeuticsMD Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing